Viewing nowRotan Tablet (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
Kips Biopharma Co., Ltd.

MFDS item code 201404243 · Approved 2014.09.17 · Insurance code 693201060
Treatment of hypertension and diabetic nephropathy in patients with hypertension and type 2 diabetes
This medication is used to treat hypertension and is particularly effective in preventing renal complications in patients with type 2 diabetes who have kidney disease. It is used to manage hypertension and improve related kidney damage.
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. Adults with hypertension: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood-pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be divided and administered orally twice daily or, if necessary, increased to 100 mg once daily. If blood pressure is not controlled with this medicine alone, it may be administered in combination with another antihypertensive medicine (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood-pressure reduction. This medicine may be administered concomitantly with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, and glucosidase inhibitors). No initial dose adjustment is necessary in elderly patients aged 75 years or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No initial dose adjustment is necessary. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. For patients who may have reduced intravascular volume (e.g., patients receiving diuretics), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). Consider administering a lower dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Children and adolescents aged 6 years or older, weighing 20 kg or more and less than 50 kg, who can swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood-pressure response. Children and adolescents aged 6 years or older, weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood-pressure response. Not recommended for children under 6 years of age, pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.
This medication can adversely affect renal development of the fetus during pregnancy, potentially causing serious harm to the fetus and newborn; therefore, it should not be used by women who are pregnant or may become pregnant. Patients with a history of allergic reactions to this medication, severe liver dysfunction, certain hereditary diseases, a history of angioedema, or specific kidney diseases should not take this medication. Elderly patients, those with reduced kidney function, patients at risk of hyperkalemia, and those with heart or vascular diseases should use this medication with extra caution and monitor their condition closely. During treatment, side effects such as dizziness, headache, muscle pain, and cough may occur, and in rare cases, serious adverse reactions such as angioedema, liver function abnormalities, kidney failure, and cardiac arrhythmias may develop; therefore, immediate consultation with a physician is necessary if such symptoms occur. This medication may cause dangerously high potassium levels in the blood when taken in combination with other antihypertensives, certain diuretics, or potassium supplements, thus concurrent use should always follow a doctor's guidance. Additionally, this medication may affect liver and kidney function, requiring careful consideration of dosing or administration for patients with liver or kidney disease, including regular blood tests and monitoring of physical status. Blood pressure may drop sharply during treatment; hence, if symptoms like dizziness or loss of consciousness occur, immediate notification to medical personnel is required, and patients undergoing hypertension treatment should regularly check their fluid and electrolyte status. If this medication is taken during pregnancy, it may affect fetal growth and kidney function, necessitating regular monitoring of fetal condition through ultrasound and close observation of the newborn for hypotension or impaired kidney function after delivery. This medication is not recommended for breastfeeding women, and it is advisable to discontinue breastfeeding while on this treatment. Moreover, this medication should not be used in children under 6 years because its safety and efficacy have not been established, and care should be taken when administering it to the elderly due to the increased possibility of side effects. In case of overdose, symptoms such as hypotension and changes in heart rate may occur, requiring immediate treatment, and since this drug is not cleared by blood dialysis, prompt medical action is crucial. While taking this medication, do not take potassium supplements or potassium-containing salt substitutes without consulting a physician, and it is advisable to avoid grapefruit juice, as it may reduce the medication's effectiveness. Finally, store this medication out of reach of children and do not transfer it to another container to maintain safety and quality.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture; it should be stored in a tightly sealed container. The recommended storage temperature is room temperature between 1 degree and 30 degrees Celsius. This helps to maintain the drug's efficacy and safety for a longer duration.
White oval film-coated tablet
For domestic use - 30 tablets/bottle, For domestic use - 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 50mg
Tablet · Prescription medication
Kips Biopharma Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.